EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 97 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,543 | -24.0% | 5,066 | 0.0% | 0.00% | – |
| Q4 2022 | $5,978 | -84.3% | 5,066 | 0.0% | 0.00% | – |
| Q3 2022 | $38,000 | +40.7% | 5,066 | +17.1% | 0.00% | – |
| Q2 2022 | $27,000 | +22.7% | 4,327 | +62.0% | 0.00% | – |
| Q1 2022 | $22,000 | +57.1% | 2,671 | 0.0% | 0.00% | – |
| Q4 2021 | $14,000 | -22.2% | 2,671 | 0.0% | 0.00% | – |
| Q3 2021 | $18,000 | -21.7% | 2,671 | 0.0% | 0.00% | – |
| Q2 2021 | $23,000 | -25.8% | 2,671 | -24.3% | 0.00% | – |
| Q1 2021 | $31,000 | -31.1% | 3,528 | -3.8% | 0.00% | – |
| Q4 2020 | $45,000 | +66.7% | 3,669 | +10.4% | 0.00% | – |
| Q3 2020 | $27,000 | -28.9% | 3,322 | -16.1% | 0.00% | – |
| Q2 2020 | $38,000 | +40.7% | 3,959 | -0.9% | 0.00% | – |
| Q1 2020 | $27,000 | -62.5% | 3,993 | -17.2% | 0.00% | – |
| Q4 2019 | $72,000 | +80.0% | 4,822 | +23.3% | 0.00% | – |
| Q3 2019 | $40,000 | -2.4% | 3,912 | 0.0% | 0.00% | – |
| Q2 2019 | $41,000 | +310.0% | 3,912 | +327.5% | 0.00% | – |
| Q1 2017 | $10,000 | 0.0% | 915 | 0.0% | 0.00% | – |
| Q4 2016 | $10,000 | – | 915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $14,118,000 | 3.56% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $12,637,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $3,044,000 | 0.52% |
| Boxer Capital, LLC | 138,331 | $1,093,000 | 0.26% |
| DAFNA Capital Management LLC | 35,977 | $284,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 223,100 | $1,762,000 | 0.12% |
| Hikari Power Ltd | 60,992 | $482,000 | 0.06% |
| Perceptive Advisors | 157,679 | $1,245,000 | 0.06% |
| Lombard Odier Asset Management (USA) Corp | 90,000 | $711,000 | 0.06% |
| TFS CAPITAL LLC | 12,128 | $96,000 | 0.04% |